Submissions from gilead.com

		Phase3 Trial:Remdesivir Significantly Reduced Risk of Hospitalization with Covid (gilead.com)
		12 points by jtbayly on Sept 29, 2021 \| past \| 13 comments
		Open Letter from Gilead CEO: Remdesivir Pricing (gilead.com)
		38 points by drinker on July 1, 2020 \| past \| 109 comments
		Ramping Up Manufacturing to Help Address Covid-19 (gilead.com)
		1 point by lawrenceyan on April 13, 2020 \| past
		An Open Letter from Our Chairman and CEO (gilead.com)
		1 point by mancerayder on April 11, 2020 \| past
		Data on 53 Patients Treated With Investigational Antiviral Remdesivir (gilead.com)
		18 points by wyxuan on April 10, 2020 \| past \| 30 comments
		Working to supply Remdesivir for COVID-19 (gilead.com)
		1 point by partingshots on April 6, 2020 \| past
		Expanded access programs for Remdesivir (gilead.com)
		128 points by mudil on April 5, 2020 \| past \| 71 comments
		Gilead’s update on response to COVID-19 using Remdesivir (gilead.com)
		19 points by jancurn on March 12, 2020 \| past \| 6 comments